Cardiovascular Research

Volume atrophy in medial temporal cortex and verbal memory scores in American Indians: Data from the Strong Heart Study.

Authors: Astrid Suchy-Dicey|||Yi Su|||Dedra S Buchwald|||Spero M Manson|||Eric M Reiman

Affiliations: + Expand

Abstract

Distinguishing Alzheimer's disease (AD) patient subgroups may optimize positive clinical outcomes. Cortical atrophy is correlated with memory deficits, but these associations are understudied in American Indians.

---

Reference List

Montine TJ, Montine KS. Precision medicine: clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’s diseases. J Exp Med. 2015;212:601–605.|||Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–292.|||Hyman BT, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement. 2012;8:1–13.|||Montine TJ, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol. 2012;123:1–11.|||Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14:535–562.|||Schmand B, Eikelenboom P, van Gool WA. Alzheimer’s Disease Neuroimaging I. Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer’s disease in younger and older age cohorts. J Am Geriatr Soc. 2011;59:1705–1710.|||Du AT, Schuff N, Amend D, et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2001;71:441–447.|||Norfray JF, Provenzale JM. Alzheimer’s disease: neuropathologic findings and recent advances in imaging. AJR Am J Roentgenol. 2004;182:3–13.|||Wang L, Benzinger TL, Hassenstab J, et al. Spatially distinct atrophy is linked to beta-amyloid and tau in preclinical Alzheimer disease. Neurology. 2015;84:1254–1260.|||Reiman EM, Jagust WJ. Brain imaging in the study of Alzheimer’s disease. Neuroimage. 2012;61:505–516.|||Weiner MW, Veitch DP, Aisen PS, et al. The Alzheimer’s Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2012;8:S1–68.|||Kohane IS. HEALTH CARE POLICY. Ten things we have to do to achieve precision medicine. Science. 2015;349:37–38.|||Mehta KM, Yaffe K, Perez-Stable EJ, et al. Race/ethnic differences in AD survival in US Alzheimer’s Disease Centers. Neurology. 2008;70:1163–1170.|||Chen HY, Panegyres PK. The role of ethnicity in Alzheimer’s disease: findings from the C-PATH online data repository. J Alzheimers Dis. 2016;51:515–523.|||Zahodne LB, Sharifian N, Kraal AZ, et al. Socioeconomic and psychosocial mechanisms underlying racial/ethnic disparities in cognition among older adults. Neuropsychology. 2021;35:265–275.|||Zahodne LB, Manly JJ, Smith J, Seeman T, Lachman ME. Socioeconomic, health, and psychosocial mediators of racial disparities in cognition in early, middle, and late adulthood. Psychol Aging. 2017;32:118–130.|||Gudala K, Bansal D, Schifano F, Bhansali A. Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig. 2013;4:640–650.|||Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer’s disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev. 2013;35:152–160.|||Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7:137–152.|||Gohdes D. Diabetes in North American Indians and Alaska Natives. Diabetes in America. 2nd ed. National Institutes of Health/NIDDK; 1995.|||Lee ET, Howard BV, Savage PJ, et al. Diabetes and impaired glucose tolerance in three American Indian populations aged 45–74 years. The Strong Heart Study. Diabetes Care. 1995;18:599–610.|||Lee ET, Welty TK, Fabsitz R, et al. The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol. 1990;132:1141–1155.|||Suchy-Dicey AM, Shibata D, Best LG, et al. Cranial magnetic resonance imaging in elderly American Indians: design, methods, and implementation of the cerebrovascular disease and its consequences in American Indians study. Neuroepidemiology. 2016;47:67–75.|||Suchy-Dicey AM, Shibata DK, Madhyastha TM, Grabowski TJ, Longstreth WT Jr, Buchwald DS. Findings of vascular brain injury and structural loss from cranial magnetic resonance imaging in elderly American Indians: the Strong Heart Study. Neuroepidemiology. 2017;48:39–47.|||Verney SP, Suchy-Dicey AM, Cholerton B, et al. The associations among sociocultural factors and neuropsychological functioning in older American Indians: the Strong Heart Study. Neuropsychology. 2019;33:1078–1088.|||Suchy-Dicey A, Shibata D, Cholerton B, et al. Cognitive correlates of MRI-defined cerebral vascular injury and atrophy in elderly American Indians: the Strong Heart Study. J Int Neuropsychol Soc. 2020;26:263–275.|||Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. 1999;9:179–194.|||Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000;97:11050–11055.|||Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–355.|||Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17:143–155.|||FreeSurfer. Cortical Reconstruction and Volumetric Segmentation as Performed Using the Freesurfer Image Analysis Suite. Center for Biomedical Imaging, Harvard University; 2016.|||Chen K, Reiman EM, Alexander GE, et al. An automated algorithm for the computation of brain volume change from sequential MRIs using an iterative principal component analysis and its evaluation for the assessment of whole-brain atrophy rates in patients with probable Alzheimer’s disease. Neuroimage. 2004;22:134–143.|||Suchy-Dicey A, Muller C, Shibata D, Howard BV, Cole SA. Comparing vascular brain injury and stroke by cranial magnetic resonance imaging, physician-adjudication, and self-report: data from the Strong Heart Study. Neuroepidemiology. 2021;55:398–406.|||Scheltens P, Launer LJ, Barkhof F, Weinstein HC, van Gool WA. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol. 1995;242:557–560.|||Duara R, Loewenstein DA, Potter E, et al. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology. 2008;71:1986–1992.|||Enkirch SJ, Traschutz A, Muller A, et al. The ERICA score: an MR imaging-based visual scoring system for the assessment of entorhinal cortex atrophy in Alzheimer disease. Radiology. 2018;288:226–333.|||Echavarri C, Aalten P, Uylings HB, et al. Atrophy in the parahippocampal gyrus as an early biomarker of Alzheimer’s disease. Brain Struct Funct. 2011;215:265–271.|||Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413–446.|||Cui D, Liu X, Liu M, et al. Subcortical gray matter structural alterations in prediabetes and type 2 diabetes. Neuroreport. 2019;30:441–445.|||Bernardes G, RG IJ, Ten Kulve JS, et al. Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin. Metab Brain Dis. 2018;33:1211–1222.|||Stephen R, Liu Y, Ngandu T, et al. Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER). Alzheimers Res Ther. 2019;11:53.|||Gu Y, Brickman AM, Stern Y, et al. Mediterranean diet and brain structure in a multiethnic elderly cohort. Neurology. 2015;85:1744–1751.|||Shu H, Shi Y, Chen G, et al. Opposite neural trajectories of apolipoprotein E 4 and 2 alleles with aging associated with different risks of Alzheimer’s disease. Cereb Cortex. 2016;26(4):1421–1429. 10.1093/cercor/bhu237|||McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–269.|||Suchy-Dicey A, Howard B, Longstreth WT Jr., Reiman EM, Buchwald D. APOE genotype, hippocampus, and cognitive markers of Alzheimer’s disease in American Indians: data from the Strong Heart Study. Alzheimers Dement. 2022.|||Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/American stroke association. Stroke. 2011;42:2672–2713.|||Weiner MF, Hynan LS, Rossetti H, et al. The relationship of cardiovascular risk factors to Alzheimer disease in Choctaw Indians. Am J Geriatr Psychiatry. 2011;19:423–429.|||Weiner MF, Rosenberg RN, Womack KB, et al. Atherosclerosis risk factors in American Indians with Alzheimer disease: preliminary findings. Alzheimer Dis Assoc Disord. 2008;22:245–248.|||Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395:795–808.|||Suchy-Dicey A, Eyituoyo H, O’Leary M, et al. Psychological and social support associations with mortality and cardiovascular disease in middle-aged American Indians: the Strong Heart Study. Soc Psychiatry Psychiatr Epidemiol. 2022;57:1421–1433.